Breast Cancer

METASTATIC HR+

Browse all METASTATIC HR+

METASTATIC HR+

Ep. 4: Ribociclib and the Evolving Role of Oral SERDs in High-Risk Disease

Laura Huppert, MD, Komal Jhaveri, MD, FACP, Heather McArthur, MD, Hope Rugo, MD, FASCO, Rahul Gosain, MD, MBA, Rohit Gosain, MD

METASTATIC HR+

Ep. 3: Abemaciclib vs Ribociclib: Clinical Decision-Making for Quality of Life

Laura Huppert, MD, Komal Jhaveri, MD, FACP, Heather McArthur, MD, Hope Rugo, MD, FASCO, Rahul Gosain, MD, MBA, Rohit Gosain, MD

METASTATIC HR+

Ep. 2: Metastatic HR-Positive Breast Cancer: Choosing the Right CDK4/6 Inhibitor

Laura Huppert, MD, Komal Jhaveri, MD, FACP, Heather McArthur, MD, Hope Rugo, MD, FASCO, Rahul Gosain, MD, MBA, Rohit Gosain, MD

METASTATIC HR+

Ep. 1: Clinical Insights: Optimizing Ribociclib, Abemaciclib, and Palbociclib Use in Metastatic HR-Positive Breast Cancer

Laura Huppert, MD, Komal Jhaveri, MD, FACP, Heather McArthur, MD, Hope Rugo, MD, FASCO, Rahul Gosain, MD, MBA, Rohit Gosain, MD

EARLY HR+

Browse all EARLY HR+

EARLY HR+

Ep. 4: Early-Stage HR-Positive Breast Cancer: Managing CDK4/6 Inhibitor Sequencing

Sara Hurvitz, MD, FACP, Sherry Shen, MD, Eleanora Teplinsky, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

EARLY HR+

Ep. 3: Liver Toxicity, Risk Stratification, and Personalized Adjuvant Therapy in Early-Stage HR-Positive Disease

Sara Hurvitz, MD, FACP, Sherry Shen, MD, Eleanora Teplinsky, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

EARLY HR+

Ep. 2: Practical Guidance for Ribociclib and Abemaciclib in the Adjuvant Setting

Sara Hurvitz, MD, FACP, Sherry Shen, MD, Eleanora Teplinsky, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

EARLY HR+

Ep. 1: Adjuvant Ribociclib in Early-Stage HR-Positive Breast Cancer: Clinical Insights

Sara Hurvitz, MD, FACP, Sherry Shen, MD, Eleanora Teplinsky, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD